CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+16.29%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.82B
AUM Growth
+$7.82B
(+20%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
875
New
65
Increased
352
Reduced
239
Closed
80
Top Buys
| 1 |
Merck
MRK
|
$46.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$29.1M |
| 3 |
Gilead Sciences
GILD
|
$27.9M |
| 4 |
BZUN
Baozun
BZUN
|
$26.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$26.5M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$81.1M |
| 2 |
Danaher
DHR
|
$31.9M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$28.1M |
| 4 |
Agilent Technologies
A
|
$28M |
| 5 |
McCormick & Company Non-Voting
MKC
|
$20.1M |
Sector Composition
| 1 | Healthcare | 33.36% |
| 2 | Technology | 16% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Communication Services | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
NVIDIA
NVDA
$4.15T
| $22.8M | 0.29% |
5,077,800
-336,520
| -6% | -$1.51M |
|
|
BHVN
77
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $22.8M | 0.29% |
442,799
-105,000
| -19% | -$5.4M |
|
|
ATVI
78
DELISTED
Activision Blizzard Inc.
ATVI
| $22.6M | 0.29% |
495,518
+256,600
| +107% | +$11.7M |
|
79
Intuitive Surgical
ISRG
$158B
| $22.2M | 0.28% |
116,922
-20,916
| -15% | -$3.98M |
|
80
Schlumberger
SLB
$52.2B
| $22M | 0.28% |
504,359
+111,901
| +29% | +$4.88M |
|
81
Elevance Health
ELV
$72.4B
| $21.7M | 0.28% |
75,749
+4,274
| +6% | +$1.23M |
|
82
Bio-Techne
TECH
$8.3B
| $21.5M | 0.28% |
433,668
+95,712
| +28% | +$4.75M |
|
|
RETA
83
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $21.3M | 0.27% |
249,200
+50,000
| +25% | +$4.27M |
|
84
Mercado Libre
MELI
$120B
| $21.3M | 0.27% |
41,926
+20,973
| +100% | +$10.6M |
|
|
SGEN
85
DELISTED
Seagen Inc. Common Stock
SGEN
| $21M | 0.27% |
286,869
+145,495
| +103% | +$10.7M |
|
86
Comcast
CMCSA
$125B
| $20.4M | 0.26% |
509,734
-398,670
| -44% | -$15.9M |
|
87
Xylem
XYL
$34B
| $20.3M | 0.26% |
257,268
+32,884
| +15% | +$2.6M |
|
88
Thermo Fisher Scientific
TMO
$183B
| $20M | 0.26% |
73,071
-14,335
| -16% | -$3.92M |
|
89
PTC
PTC
$25.4B
| $19.8M | 0.25% |
214,696
-19,846
| -8% | -$1.83M |
|
|
CLVS
90
DELISTED
Clovis Oncology, Inc.
CLVS
| $19.4M | 0.25% |
781,623
+488,523
| +167% | +$12.1M |
|
91
Intuit
INTU
$187B
| $19.4M | 0.25% |
74,164
-13,842
| -16% | -$3.62M |
|
|
NAVG
92
DELISTED
Navigators Group Inc
NAVG
| $19.1M | 0.24% |
273,901
+111,401
| +69% | +$7.78M |
|
93
DuPont de Nemours
DD
$31.6B
| $19M | 0.24% |
166,426
+18,512
| +13% | +$2.12M |
|
94
Booking.com
BKNG
$181B
| $18.9M | 0.24% |
10,797
+5,324
| +97% | +$9.3M |
|
95
Palo Alto Networks
PANW
$128B
| $18.4M | 0.24% |
455,076
-47,382
| -9% | -$1.92M |
|
96
Analog Devices
ADI
$120B
| $18.4M | 0.24% |
174,894
+44,413
| +34% | +$4.68M |
|
97
MetLife
MET
$53.6B
| $18M | 0.23% |
392,146
-19,783
| -5% | -$909K |
|
|
IMMU
98
DELISTED
Immunomedics Inc
IMMU
| $18M | 0.23% |
935,887
+39,511
| +4% | +$759K |
|
99
CBRE Group
CBRE
$47.3B
| $17.6M | 0.23% |
332,710
+56,339
| +20% | +$2.98M |
|
100
Starbucks
SBUX
$99.2B
| $17.4M | 0.22% |
234,462
+40,911
| +21% | +$3.04M |
|